An analysis of ovarian cancer in the Million Women Study

Gynecological Endocrinology

Volumn 23, Issue 7, 2007, Pages 410-413

  Neves E Castro, Manuel ^a,b  

^a Portuguese Menopause Society   (Portugal)

^b NONE   (Portugal)

Author keywords

HRT; MWS; Ovarian cancer

Indexed keywords

ANDROGEN RECEPTOR; CYTOKINE; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GROWTH FACTOR; PROGESTERONE RECEPTOR;

ANALYTIC METHOD; ARTICLE; BODY MASS; CANCER RISK; CONFIDENCE INTERVAL; HAZARD RATIO; HORMONE SUBSTITUTION; HUMAN; IMMOBILIZATION; IMMUNITY; MENOPAUSE; NULLIPARA; OBESITY; OVARY CANCER; POSTMENOPAUSE; PRIORITY JOURNAL; QUALITY OF LIFE; RISK; RISK FACTOR; SMOKING; SMOKING CESSATION; STATISTICAL SIGNIFICANCE;

ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; LONGITUDINAL STUDIES; ODDS RATIO; OVARIAN NEOPLASMS; PORTUGAL; POSTMENOPAUSE; RISK;

EID: 34548129215     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.1080/09513590701483910     Document Type: Article

References (21)

1. Beral V. Million Women Study Collaborators. Ovarian cancer and hormone replacement therapy in the Million Women Study. The Lancet 2007;369:1703-1710.
2. Neves-e-Castro M. Why do some breast cancer cells remain dormant? Gynecol Endocrinol 2006;22:190-197.
3. Meltzer A. Dormancy and breast cancer. J Surg Oncol 1990;43:181-188.
4. Wong AS, Leung PC. Role of endocrine and growth factors on the ovarian surface epithelium. J Obstet Gynaecol Res 2007;33:3-16.
5. Juengel JL, Heath DA, Quirke LD, McNatty KP. Oestrogen receptor α and β, androgen receptor and progesterone receptor mRNA and protein localisation within the developing ovary and in small growing follicles of sheep. Reproduction 2006;131:81-92.
6. D'Haeseleer M, Van Poucke M, Van den Broeck W. Cell-specific localization of oestrogen receptor β (ESR2) mRNA within various bovine ovarian cell types using in situ hybridization. Anat Histol Embryol 2005;34:265-272.
7. Buckanovich RJ, Sasaroli D, O'Brien-Jenkins A, Botbyl J, Hammond R, Katsaros D, Sandaltzopoulos R, Liotta LA, Gimotty PA, Coukos G. Tumor vascular proteins as biomarkers in ovarian cancer. J Clin Oncol 2007;25:852-861.
8. Nielsen M, Thomsen JL, Primdahl S, Dyreborg U, Andersen JA. Breast cancer and atypia among young and middle-aged women: a study of 110 medicolegal autopsies. Br J Cancer 1987;56:814-819.
9. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. J Am Med Assoc 2002;288:321-333.
10. Grodstein F, Manson JE, Colditz GA, Willett WC, Speizer FE, Stampfer MJ. A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease. Ann Intern Med 2000;133:933-941.
11. Lacey JV, Brinton LA, Leitzmann MF, Mouw T, Hollenbeck A, Schatzkin A, Hartge P. Menopausal hormone therapy and ovarian cancer risk in the National Institutes of Health-AARP Diet and Health Study Cohort. J Natl Cancer Inst 2006;98:1397-1405.
12. Beehler GP, Sekhon M, Baker JA, Teter BE, McCann SE, Rodabaugh KJ, Moysich KB. Risk of ovarian cancer associated with BMI varies by menopausal status. J Nutr 2006;136:2281-2286.
13. Yang CY, Kuo HW, Chiu HF. Age at first birth, parity, and risk of death from ovarian cancer in Taiwan: a country of low incidence of ovarian cancer. Int J Gynecol Cancer 2007;17:32-36.
14. Olsen CM, Green AC, Whiteman DC, Sadeghi S, Kolahdooz F, Webb PM. Obesity and the risk of epithelial ovarian cancer: a systematic review and meta-analysis. Eur J Cancer 2007;43:690-709.
15. Jordan SJ, Whiteman DC, Purdie DM, Green AC, Webb PM. Does smoking increase risk of ovarian cancer? A systematic review. Gynecol Oncol 2006;103:1122-1129.
16. Peterson NB, Trentham-Dietz A, Newcomb PA, Chen Z, Hampton JM, Willett WC, Egan KM. Alcohol consumption and ovarian cancer risk in a population-based case-control study. Int J Cancer 2006;119:2423-2427.
17. Rossing MA, Tang MT, Flagg EW, Weiss LK, Wicklund KG, Weiss NS. Body size and risk of epithelial ovarian cancer (United States). Cancer Causes Control 2006;17:713-720.
18. Greer JB, Modugno F, Ness RB, Allen GO. Anthropometry and the risk of epithelial ovarian cancer. Cancer 2006;106:2247-2257.
19. Baker JA, Odunuga OO, Rodabaugh KJ, Reid ME, Menezes RJ, Moysich KB. Active and passive smoking and risk of ovarian cancer. Int J Gynecol Cancer 2006;16(Suppl 1):211-218.
20. Patel AV, Rodriguez C, Pavluck AL, Thun MJ, Calle EE. Recreational physical activity and sedentary behavior in relation to ovarian cancer risk in a large cohort of US women. Am J Epidemiol 2006;163:709-716.
21. Abenhaim HA, Titus-Ernstoff L, Cramer DW. Ovarian cancer risk in relation to medical visits, pelvic examinations and type of health care provider. Can Med Assoc J 2007;176:941-947.